Warning! GuruFocus detected
4 Severe warning signs
with MVP.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Medical Developments International Ltd
NAICS : 621399
ISIN : AU000000MVP2
Description
Medical Developments International Ltd is a specialized healthcare company. It manufactures and distributes the pharmaceutical drug and medical and veterinary equipment. The company provides a range of products in the areas of pain management, asthma, and resuscitation, plus veterinary equipment. It is organized into three business units: Pharmaceuticals, Medical Devices, and Veterinary products. Majority of its revenue comes from Pharmaceuticals Unit which engages in the sale of Penthrox within Australia, New Zealand, Europe the UK and some sales in Canada, the Middle East, Asia and South Africa.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.23 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.04 | |||||
| Debt-to-EBITDA | -0.13 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 0.3 | |||||
| Beneish M-Score | -3.91 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.8 | |||||
| 3-Year EBITDA Growth Rate | -28.4 | |||||
| 3-Year EPS without NRI Growth Rate | -67.4 | |||||
| 3-Year FCF Growth Rate | 10.1 | |||||
| 3-Year Book Growth Rate | -17.5 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 14.28 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.06 | |||||
| 9-Day RSI | 36.17 | |||||
| 14-Day RSI | 40.22 | |||||
| 3-1 Month Momentum % | 65.43 | |||||
| 6-1 Month Momentum % | 52.27 | |||||
| 12-1 Month Momentum % | 14.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.24 | |||||
| Quick Ratio | 4.15 | |||||
| Cash Ratio | 2.76 | |||||
| Days Inventory | 307.94 | |||||
| Days Sales Outstanding | 62.75 | |||||
| Days Payable | 283.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6 | |||||
| Shareholder Yield % | -14.29 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.8 | |||||
| Operating Margin % | -9.69 | |||||
| Net Margin % | -78.16 | |||||
| FCF Margin % | -18.23 | |||||
| ROE % | -50.48 | |||||
| ROA % | -41.4 | |||||
| ROIC % | -11.11 | |||||
| 3-Year ROIIC % | 76.8 | |||||
| ROC (Joel Greenblatt) % | -112.22 | |||||
| ROCE % | -31.43 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 6.52 | |||||
| PS Ratio | 1.45 | |||||
| PB Ratio | 1.13 | |||||
| Price-to-Tangible-Book | 1.91 | |||||
| EV-to-EBIT | -2.39 | |||||
| EV-to-Forward-EBIT | -8.79 | |||||
| EV-to-EBITDA | -2.89 | |||||
| EV-to-Revenue | 1.23 | |||||
| EV-to-Forward-Revenue | 4.28 | |||||
| EV-to-FCF | -6.54 | |||||
| Price-to-GF-Value | 0.34 | |||||
| Price-to-Median-PS-Value | 0.1 | |||||
| Price-to-Net-Current-Asset-Value | 2.64 | |||||
| Price-to-Net-Cash | 7.93 | |||||
| Earnings Yield (Greenblatt) % | -41.92 | |||||
| FCF Yield % | -11.09 | |||||
| Forward Rate of Return (Yacktman) % | -1.74 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medical Developments International Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 38.054 | ||
| EPS (TTM) (A$) | -0.336 | ||
| Beta | 2.69 | ||
| 3-Year Sharpe Ratio | -0.36 | ||
| 3-Year Sortino Ratio | -0.6 | ||
| Volatility % | 78.84 | ||
| 14-Day RSI | 40.22 | ||
| 14-Day ATR (A$) | 0.041018 | ||
| 20-Day SMA (A$) | 0.607 | ||
| 12-1 Month Momentum % | 14.64 | ||
| 52-Week Range (A$) | 0.365277 - 0.94 | ||
| Shares Outstanding (Mil) | 112.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medical Developments International Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medical Developments International Ltd Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medical Developments International Ltd Frequently Asked Questions
What is Medical Developments International Ltd(ASX:MVP)'s stock price today?
The current price of ASX:MVP is A$0.56. The 52 week high of ASX:MVP is A$0.94 and 52 week low is A$0.37.
When is next earnings date of Medical Developments International Ltd(ASX:MVP)?
The next earnings date of Medical Developments International Ltd(ASX:MVP) is .
Does Medical Developments International Ltd(ASX:MVP) pay dividends? If so, how much?
Medical Developments International Ltd(ASX:MVP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers